Histology of an undisplaced femoral fatigue fracture in association with bisphosphonate treatment. Frozen bone with remodelling at the crack.
Aspenberg
Per
P
Department of Orthopaedics, IKE, Faculty of Health Sciences, Linköping University, Sweden. per.aspenberg@liu.se
Schilcher
Jörg
J
Fahlgren
Anna
A
D019386:Alendronate / Q000008:administration & dosage / Q000009:adverse effects; D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001858:Bone Nails; D001862:Bone Resorption / Q000139:chemically induced / Q000473:pathology; D012968:Etidronic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D005260:Female; D005264:Femoral Fractures / Q000139:chemically induced / Q000000981:diagnostic imaging / Q000473:pathology* / Q000601:surgery; D005594:Fracture Fixation, Intramedullary / Q000379:methods; D015775:Fractures, Stress / Q000139:chemically induced / Q000000981:diagnostic imaging / Q000473:pathology* / Q000601:surgery; D006801:Humans; D008875:Middle Aged; D011859:Radiography; D000068296:Risedronic Acid
D050071:Bone Density Conservation Agents; D000068296:Risedronic Acid; D012968:Etidronic Acid; D019386:Alendronate